Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Bozeman · SciRah

Researcher profile · Semantic Scholar

L. Bozeman

Share profile

L. Bozeman — researcher profile on SciRah

h-index: 19
Works: 27
Citations: 3,216

Most-cited papers

Three months of rifapentine and isoniazid for latent tuberculosis infection.
T. Sterling, M. Villarino, A. Borisov, N. Shang +13 more
2011New England Journal of Medicine893 citations Open access
Semantic Scholar
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
D. Benator, Mondira Bhattacharya, L. Bozeman, W. Burman +15 more
2002The Lancet405 citations
Semantic Scholar
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
T. Samandari, T. Agizew, S. Nyirenda, Z. Tedla +12 more
2011The Lancet365 citations
Semantic Scholar
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
A. Vernon, W. Burman, D. Benator, Awal Khan +1 more
1999The Lancet322 citations
Semantic Scholar
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
S. Dorman, J. E. Johnson, S. Goldberg, Grace Muzanye +15 more
2009American Journal of Respiratory and Critical Care Medicine265 citations
Semantic Scholar
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?
R. Jasmer, L. Bozeman, K. Schwartzman, M. Cave +4 more
2004American Journal of Respiratory and Critical Care Medicine152 citations
Semantic Scholar
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
S. Dorman, R. Savic, S. Goldberg, J. Stout +14 more
2015American Journal of Respiratory and Critical Care Medicine116 citations Open access
Semantic Scholar
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
S. Dorman, S. Goldberg, J. Stout, G. Muzanyi +14 more
2012Journal of Infectious Diseases108 citations
Semantic Scholar
A viral disease of fledgling budgerigars.
R. Davis, L. Bozeman, D. Gaudry, O. Fletcher +2 more
1981Avian diseases94 citations
Semantic Scholar
Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.
L. Bozeman, W. Burman, B. Metchock, Lauren Welch +1 more
2005Clinical Infectious Diseases68 citations Open access
Semantic Scholar
Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection.
T. Spira, L. Bozeman, K. C. Sanderlin, D. Warfield +5 more
1990Journal of Infectious Diseases67 citations
Semantic Scholar
A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy.
J. Kaplan, T. Spira, D. Fishbein, L. Bozeman +2 more
1988Journal of the American Medical Association (JAMA)54 citations
Semantic Scholar
Mycobacterium tuberculosis Specific CD8+ T Cells Rapidly Decline with Antituberculosis Treatment
Melissa Nyendak, Byung Park, Megan Null, J. Baseke +12 more
2013PLoS ONE51 citations Open access
Semantic Scholar
Relapse Associated with Active Disease Caused by Beijing Strain of Mycobacterium tuberculosis
W. Burman, E. Bliven, L. Cowan, L. Bozeman +3 more
2009Emerging Infectious Diseases46 citations Open access
Semantic Scholar
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: study protocol for TBTC Study 31/ACTG A5349 phase 3 clinical trial
S. Dorman, Payam Nahid, E. Kurbatova, S. Goldberg +28 more
2020Contemporary Clinical Trials40 citations Open access
Semantic Scholar
A light and electron microscopic examination of budgerigar fledgling disease virus in tissue and in cell culture.
M. J. Dykstra, L. Bozeman
1982Avian Pathology38 citations Open access
Semantic Scholar
Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa
William R. Mac Kenzie, C. Heilig, L. Bozeman, J. E. Johnson +8 more
2011PLoS ONE36 citations Open access
Semantic Scholar
What is the most reliable solid culture medium for tuberculosis treatment trials?
M. Joloba, J. E. Johnson, Pei-Jean I. Feng, L. Bozeman +7 more
2014Tuberculosis23 citations
Semantic Scholar
Human immunodeficiency virus viremia as a prognostic indicator in homosexual men with lymphadenopathy syndrome.
T. Spira, J. Kaplan, P. Feorino, D. Warfield +2 more
1987New England Journal of Medicine21 citations
Semantic Scholar
Mycoplasma challenge studies in budgerigars (Melopsittacus undulatus) and chickens.
L. Bozeman, S. Kleven, R. Davis
1984Avian diseases15 citations
Semantic Scholar
A Phase II Study Of A Rifapentine-Containing Regimen For Intensive Phase Treatment Of Pulmonary Tuberculosis: Preliminary Results For Tuberculosis Trials Consortium Study 29
S. Dorman, S. Goldberg, Pei-Jean I. Feng, C. Heilig +13 more
2011Asian Test Symposium13 citations
Semantic Scholar
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
R. Reves, C. Heilig, Jan Tapy, L. Bozeman +7 more
2014The International Journal of Tuberculosis and Lung Disease12 citations
Semantic Scholar
How we determined the most reliable solid medium for studying treatment of tuberculosis
C. Heilig, Pei-Jean I. Feng, M. Joloba, J. E. Johnson +7 more
2014Tuberculosis6 citations Open access
Semantic Scholar
Three Months of Weekly Rifapentine plus Isoniazid for Treatment of M. tuberculosis Infection in HIV Co-infected Persons
M. Sterling, M. Scott, M. Miró, M. G. Calvet +11 more
5 citations
Semantic Scholar
Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen
Kimberley N. Chapman Hedges, A. Borisov, J. Saukkonen, N. Scott +8 more
2019Clinical Trials3 citations Open access
Semantic Scholar
Deterioration in immunologic status of human immunodeficiency virus (HIV)-infected homosexual men with lymphadenopathy: Prognostic implications
T. Spira, J. Kaplan, R. Holman, L. Bozeman +2 more
1989Journal of Clinical Immunology1 citations
Semantic Scholar
Evaluating The Efficacy And Safety Of Intermittent Tuberculosis (TB) Treatment When Isoniazid (INH) Cannot Be Used
R. Reves, C. Hamilton, Jan Tapy, M. Narita +4 more
2011Asian Test Symposium0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Goldberg×12
Invite
S. Goldberg — researcher profile on SciRah
C. Heilig×10
Invite
C. Heilig — researcher profile on SciRah
J. E. Johnson×9
Invite
J. E. Johnson — researcher profile on SciRah
M. Weiner×7
Invite
M. Weiner — researcher profile on SciRah

×7

Invite

A. Vernon — researcher profile on SciRah

Invite

S. Dorman — researcher profile on SciRah

Pei-Jean I. Feng×6

Invite

Pei-Jean I. Feng — researcher profile on SciRah

Invite

W. Burman — researcher profile on SciRah

Invite

B. Metchock — researcher profile on SciRah

Invite

Payam Nahid — researcher profile on SciRah

Invite

R. Chaisson — researcher profile on SciRah

Invite

T. Spira — researcher profile on SciRah